Walleye Capital’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,548
| Closed | -$90.1K | – | 2211 |
|
|
2024
Q4 | $90.1K | Buy |
+10,548
| New | +$90.1K | ﹤0.01% | 1707 |
|
|
2024
Q2 | – | Sell |
-82,058
| Closed | -$747K | – | 2875 |
|
|
2024
Q1 | $747K | Buy |
+82,058
| New | +$747K | ﹤0.01% | 1190 |
|
|
2023
Q3 | – | Sell |
-43,665
| Closed | -$225K | – | 2761 |
|
|
2023
Q2 | $225K | Buy |
43,665
+24,854
| +132% | +$128K | ﹤0.01% | 1284 |
|
|
2023
Q1 | $99.1K | Buy |
+18,811
| New | +$99.1K | ﹤0.01% | 1513 |
|
|
2022
Q2 | – | Sell |
-15,482
| Closed | -$77K | – | 2559 |
|
|
2022
Q1 | $77K | Sell |
15,482
-55,973
| -78% | -$278K | ﹤0.01% | 1730 |
|
|
2021
Q4 | $498K | Buy |
+71,455
| New | +$498K | 0.02% | 964 |
|
|
2020
Q3 | – | Sell |
-34,700
| Closed | -$289K | – | 922 |
|
|
2020
Q2 | $289K | Buy |
34,700
+23,700
| +215% | +$197K | 0.06% | 344 |
|
|
2020
Q1 | $55K | Buy |
+11,000
| New | +$55K | 0.01% | 418 |
|